Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
Amgen Inc. (NASDAQ:AMGN) Stake Cut by EverSource Wealth Advisors LLC
Advisors Asset Management Inc. Sells 2,325 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by First Horizon Advisors Inc.
Amgen appoints Howard Chang as new chief scientific officer By Investing.com
Amgen Appoints Howard Chang as SVP of Research By Investing.com
Jennison Associates LLC Sells 78,759 Shares of Amgen Inc. (NASDAQ:AMGN)
Commerce Bank Buys 5,119 Shares of Amgen Inc. (NASDAQ:AMGN)
Strategy Asset Managers LLC Sells 2,761 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen, Coke Set Aside Only Fraction of Billions They May Owe IRS
Short Interest in Amgen Inc. (NASDAQ:AMGN) Decreases By 5.9% - Zolmax
Amgen Inc. (NASDAQ:AMGN) Receives $333.57 Average PT from Analysts
SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels - November 20, 2024 - Zacks.com
Second Half Financial Partners LLC Buys Shares of 10,591 Amgen Inc. (NASDAQ:AMGN)
Banque Cantonale Vaudoise Cuts Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Pathstone Holdings LLC
Amgen Inc. (NASDAQ:AMGN) is Smead Capital Management Inc.'s 6th Largest Position
Meeder Asset Management Inc. Increases Holdings in Amgen Inc. (NASDAQ:AMGN)
MAI Capital Management Sells 5,862 Shares of Amgen Inc. (NASDAQ:AMGN)
AMG National Trust Bank Trims Position in Amgen Inc. (NASDAQ:AMGN)
Amgen (NASDAQ:AMGN) Now Covered by Analysts at Wolfe Research
Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?
Napa Wealth Management Acquires New Position in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Short Interest Update | MarketBeat
Radiopharm Theranostics CEO Shares Company Milestones as NASDAQ Listing Nears
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It - November 18, 2024 - Zacks.com
Thrivent Financial for Lutherans Trims Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
Sawgrass Asset Management LLC Sells 11,850 Shares of Amgen Inc. (NASDAQ:AMGN)
Natixis Advisors LLC Has $94.32 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)
GSA Capital Partners LLP Takes Position in Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Given Consensus Rating of "Hold" by Analysts
Amgen (NASDAQ:AMGN) Upgraded to “Hold” at Citigroup
Kinsale Capital Group Inc. Raises Holdings in Amgen Inc. (NASDAQ:AMGN)
Northcape Wealth Management LLC Increases Position in Amgen Inc. (NASDAQ:AMGN)
AMGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Amgen Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm | Morningstar
Amgen, Merck stocks dive as Trump picks anti-vaxxer RFK Jr. to lead US healthcare
Amgen (NASDAQ:AMGN) Raised to Hold at Citigroup
Dearborn Partners LLC Has $1.15 Million Stock Position in Amgen Inc. (NASDAQ:AMGN)
Check Capital Management Inc. CA Acquires 75 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen (NASDAQ:AMGN) Coverage Initiated by Analysts at Wolfe Research
CIBC Asset Management Inc Buys 16,134 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen (NASDAQ:AMGN) Stock Rating Upgraded by Citigroup
Jim Cramer shakes up stock watchlist — 3 are out, rest stick around
Amgen’s (AMGN) “Outperform” Rating Reiterated at William Blair
Amgen’s (AMGN) Buy Rating Reaffirmed at Jefferies Financial Group
Lifeworks Advisors LLC Sells 168 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Decreased by Lifeworks Advisors LLC
Amgen Inc. (NASDAQ:AMGN) Shares Sold by ING Groep NV
Citi initiates coverage on 5 new biotech stocks By Investing.com
KBC Group NV Raises Position in Amgen Inc. (NASDAQ:AMGN)
Bell Bank Cuts Stake in Amgen Inc. (NASDAQ:AMGN)
Is Wall Street Bullish or Bearish on Amgen Stock?
Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate - November 14, 2024 - Zacks.com
MOORE LAW ENCOURAGES AMGEN INC. INVESTORS TO CONTACT LAW FIRM | Morningstar
Trade Tracker: Joe Terranova sells Amgen and buys XBI
No link between experimental weight loss drug and change in bone density, Amgen says
Syros slammed by phase III data with tamibarotene in MDS | BioWorld
Arjuna Capital Lowers Stock Position in Amgen Inc. (NASDAQ:AMGN)
Morning Brew: Amgen's Rebound, Flutter's Buyback, and Cybersecurity Surge
Citi sets Amgen neutral with $335 target on MariTide focus By Investing.com
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Rakuten Securities Inc.
Buck Wealth Strategies LLC Cuts Stake in Amgen Inc. (NASDAQ:AMGN)
Aptus Capital Advisors LLC Buys 5,515 Shares of Amgen Inc. (NASDAQ:AMGN)
Amgen Says No Link Between MariTide, Bone Density Loss | Morningstar
Amgen sees no bone safety concerns around experimental obesity drug, ETPharma
Amgen Says No Link Between MariTide And Changes In Bone Mineral Density
AMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA | Morningstar
Amgen Issues Statement on MariTide Phase 1 data By Investing.com
Amgen sees no bone safety concerns around experimental obesity drug By Reuters
Wall Street indexes dip with focus on Trump policies, economic data
Amgen stock holds steady as company dismisses analyst report | BioWorld
Amgen sinks as Cantor flags issues with obesity drug
Dollar rally continues while T-Notes are sold ahead of CPI - Newsquawk US Market Wrap
Amgen Inc. (NASDAQ:AMGN) Stock Position Cut by Victory Capital Management Inc.
Jaffetilchin Investment Partners LLC Increases Stock Position in Amgen Inc. (NASDAQ:AMGN)
USFDA gives nod to Alembic Pharma’s genetic formulation to treat heart failure
Proactive Wealth Strategies LLC Acquires New Holdings in Amgen Inc. (NASDAQ:AMGN)
BMO maintains Outperform on Amgen, price target at $362 By Investing.com
Barclays maintains Amgen at Equalweight with $315 target By Investing.com
Amgen (NASDAQ:AMGN) Earns "Outperform" Rating from William Blair
Winslow Asset Management Inc. Has $6.93 Million Holdings in Amgen Inc. (NASDAQ:AMGN)
Jefferies maintains buy on Amgen, keeps $380 target By Investing.com
WealthPlan Investment Management LLC Has $12.55 Million Holdings in Amgen Inc. (NASDAQ:AMGN)
WealthPLAN Partners LLC Acquires 1,594 Shares of Amgen Inc. (NASDAQ:AMGN)
Cantor maintains $405 target on Amgen amid new data By Investing.com
WCM Investment Management LLC Raises Stock Position in Amgen Inc. (NASDAQ:AMGN)
TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV) | Markets Insider
Alembic Pharmaceuticals receives USFDA approval for Ivabradine Tablets | Capital Market News - Business Standard
deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk - PR Newswire APAC
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Nations Financial Group Inc. IA ADV
Core Wealth Partners LLC Purchases 449 Shares of Amgen Inc. (NASDAQ:AMGN)
Baker Avenue Asset Management LP Buys 1,662 Shares of Amgen Inc. (NASDAQ:AMGN)
Colonial River Investments LLC Trims Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
Axxcess Wealth Management LLC Sells 2,426 Shares of Amgen Inc. (NASDAQ:AMGN)
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Arrow Financial Corp
First Personal Financial Services Reduces Holdings in Amgen Inc. (NASDAQ:AMGN)
CWA Asset Management Group LLC Purchases New Position in Amgen Inc. (NASDAQ:AMGN)
Objective Capital Management LLC Invests $443,000 in Amgen Inc. (NASDAQ:AMGN)
Latest news
MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K
Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024